Lv41
788 积分 2023-06-24 加入
Development and validation of a UHPLC-MS/MS method to measure cefotaxime and metabolite desacetylcefotaxime in blood plasma: a pilot study suitable for capillary microsampling in critically ill children
42分钟前
待确认
ANXA1 Promotes Endoplasmic Reticulum–Mitochondria Calcium Coupling to Sustain Lenvatinib Resistance in Hepatocellular Carcinoma
25天前
已完结
Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma
29天前
已完结
ACSL5 drives pancreatic ductal adenocarcinoma by suppressing mitophagy and enhancing ferroptosis resistance via the JAK1-STAT1-OASL axis
29天前
已完结
MICAL2 as a key effector of β-catenin signaling driving melanoma progression and therapeutic resistance
29天前
已完结
213Bi (Alpha-emitter)-Antibody Targeting of Breast Cancer Metastases in the neu-N Transgenic Mouse Model
1个月前
已关闭
Discovery, Optimization, and Evaluation of Potent and Selective PDGFRβ Inhibitors for the Treatment of Hepatocellular Carcinoma
3个月前
已完结
Chemical discovery of a novel MD2/ADAM17 dual-target inhibitor as a potential therapeutic candidate for saturated fatty acid-induced myocardial inflammatory injury
3个月前
已完结
EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
4个月前
已完结
EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
4个月前
已关闭
皖公网安备34019202002308
